Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 3 | 2022 | 561 | 0.830 |
Why?
|
| Neutrophils | 3 | 2020 | 204 | 0.790 |
Why?
|
| Monocytes | 1 | 2022 | 210 | 0.780 |
Why?
|
| Extracellular Traps | 2 | 2016 | 9 | 0.680 |
Why?
|
| Intestine, Small | 2 | 2018 | 89 | 0.670 |
Why?
|
| Neoplasms | 3 | 2022 | 1667 | 0.650 |
Why?
|
| Antibodies | 1 | 2018 | 241 | 0.590 |
Why?
|
| Microbiota | 1 | 2018 | 80 | 0.590 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2009 | 79 | 0.560 |
Why?
|
| Thrombophilia | 1 | 2016 | 21 | 0.560 |
Why?
|
| Hepacivirus | 2 | 2009 | 90 | 0.560 |
Why?
|
| Carcinogenesis | 2 | 2020 | 124 | 0.540 |
Why?
|
| Hepatitis C | 2 | 2009 | 114 | 0.530 |
Why?
|
| Receptors, Complement | 1 | 2016 | 58 | 0.520 |
Why?
|
| Blood Coagulation | 1 | 2016 | 123 | 0.520 |
Why?
|
| Complement System Proteins | 1 | 2016 | 135 | 0.510 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 2011 | 11 | 0.460 |
Why?
|
| Immunodominant Epitopes | 3 | 2009 | 13 | 0.430 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2019 | 266 | 0.430 |
Why?
|
| Complement Activation | 3 | 2021 | 145 | 0.430 |
Why?
|
| Toxoplasmosis | 3 | 2006 | 13 | 0.410 |
Why?
|
| Antigens, Protozoan | 3 | 2006 | 10 | 0.410 |
Why?
|
| HIV-1 | 2 | 2011 | 177 | 0.400 |
Why?
|
| Toxoplasma | 3 | 2006 | 23 | 0.400 |
Why?
|
| Immunity, Cellular | 2 | 2009 | 80 | 0.380 |
Why?
|
| Inflammation | 3 | 2022 | 1030 | 0.360 |
Why?
|
| Inverted Repeat Sequences | 1 | 2010 | 4 | 0.360 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2021 | 122 | 0.350 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2010 | 37 | 0.350 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2009 | 38 | 0.340 |
Why?
|
| Intestinal Neoplasms | 2 | 2020 | 30 | 0.310 |
Why?
|
| Neoplasm Metastasis | 2 | 2021 | 306 | 0.300 |
Why?
|
| Toxoplasmosis, Congenital | 2 | 2006 | 4 | 0.300 |
Why?
|
| Colitis | 2 | 2019 | 156 | 0.290 |
Why?
|
| Animals | 12 | 2022 | 20881 | 0.290 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2006 | 41 | 0.280 |
Why?
|
| Macrophages | 3 | 2022 | 647 | 0.270 |
Why?
|
| Membrane Proteins | 3 | 2020 | 617 | 0.260 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 213 | 0.230 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 35 | 0.230 |
Why?
|
| Humans | 21 | 2022 | 68618 | 0.230 |
Why?
|
| Immunotherapy | 2 | 2022 | 215 | 0.220 |
Why?
|
| Flow Cytometry | 2 | 2021 | 489 | 0.210 |
Why?
|
| Molecular Sequence Data | 5 | 2011 | 1447 | 0.210 |
Why?
|
| Anaphylatoxins | 1 | 2022 | 3 | 0.210 |
Why?
|
| Colonic Neoplasms | 3 | 2021 | 299 | 0.210 |
Why?
|
| Immunologic Factors | 1 | 2022 | 87 | 0.200 |
Why?
|
| Amino Acid Sequence | 4 | 2009 | 1083 | 0.200 |
Why?
|
| Brain Injury, Chronic | 1 | 2021 | 4 | 0.200 |
Why?
|
| Disease Susceptibility | 1 | 2022 | 179 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 2791 | 0.190 |
Why?
|
| Trinucleotide Repeats | 2 | 2011 | 8 | 0.190 |
Why?
|
| Adipokines | 1 | 2021 | 20 | 0.190 |
Why?
|
| Down-Regulation | 1 | 2022 | 447 | 0.190 |
Why?
|
| Bacteria | 2 | 2021 | 193 | 0.190 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 48 | 0.180 |
Why?
|
| Firmicutes | 1 | 2020 | 4 | 0.180 |
Why?
|
| Drug Discovery | 1 | 2021 | 94 | 0.180 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2020 | 14 | 0.180 |
Why?
|
| Immune Evasion | 1 | 2020 | 19 | 0.170 |
Why?
|
| Mice | 6 | 2022 | 8474 | 0.170 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2021 | 105 | 0.170 |
Why?
|
| Proteolysis | 1 | 2020 | 97 | 0.170 |
Why?
|
| Thrombin | 1 | 2020 | 117 | 0.170 |
Why?
|
| Intestines | 1 | 2020 | 114 | 0.170 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2018 | 17 | 0.160 |
Why?
|
| Blood Platelets | 1 | 2020 | 284 | 0.160 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 2550 | 0.160 |
Why?
|
| Immune Tolerance | 1 | 2019 | 114 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 446 | 0.160 |
Why?
|
| Immunity | 1 | 2018 | 67 | 0.160 |
Why?
|
| Cell Differentiation | 1 | 2022 | 1034 | 0.150 |
Why?
|
| Interleukin-10 | 1 | 2018 | 144 | 0.150 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 219 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 199 | 0.150 |
Why?
|
| Diet | 1 | 2021 | 514 | 0.140 |
Why?
|
| Sequence Alignment | 2 | 2009 | 165 | 0.140 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2018 | 87 | 0.140 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 334 | 0.140 |
Why?
|
| Evolution, Molecular | 2 | 2009 | 79 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 207 | 0.140 |
Why?
|
| Adult | 9 | 2020 | 21403 | 0.140 |
Why?
|
| Disease Progression | 2 | 2020 | 1038 | 0.140 |
Why?
|
| Vitamin D | 1 | 2021 | 516 | 0.140 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2016 | 26 | 0.140 |
Why?
|
| Hemostasis | 1 | 2016 | 32 | 0.130 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2016 | 41 | 0.130 |
Why?
|
| Hematopoiesis | 1 | 2016 | 108 | 0.130 |
Why?
|
| Mice, Knockout | 2 | 2019 | 1692 | 0.130 |
Why?
|
| Complement Pathway, Alternative | 1 | 2016 | 69 | 0.130 |
Why?
|
| Interferon-gamma | 2 | 2006 | 241 | 0.120 |
Why?
|
| Melanoma | 1 | 2018 | 335 | 0.120 |
Why?
|
| Anticoagulants | 1 | 2016 | 356 | 0.120 |
Why?
|
| Mutagenesis, Insertional | 2 | 2011 | 24 | 0.110 |
Why?
|
| Phenotype | 1 | 2016 | 947 | 0.110 |
Why?
|
| Middle Aged | 6 | 2021 | 21147 | 0.110 |
Why?
|
| Genetic Variation | 2 | 2011 | 220 | 0.100 |
Why?
|
| Phylogeny | 2 | 2011 | 197 | 0.100 |
Why?
|
| Brain | 2 | 2021 | 2176 | 0.100 |
Why?
|
| Models, Biological | 1 | 2016 | 981 | 0.100 |
Why?
|
| Purines | 1 | 2011 | 39 | 0.100 |
Why?
|
| HIV Seropositivity | 1 | 2011 | 66 | 0.100 |
Why?
|
| Female | 11 | 2021 | 38074 | 0.100 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2011 | 51 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 1173 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 4848 | 0.090 |
Why?
|
| Pyrimidines | 1 | 2011 | 178 | 0.090 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2011 | 133 | 0.090 |
Why?
|
| Genes, env | 1 | 2010 | 2 | 0.090 |
Why?
|
| Frameshift Mutation | 1 | 2010 | 8 | 0.090 |
Why?
|
| Biomarkers | 3 | 2021 | 1593 | 0.090 |
Why?
|
| Male | 9 | 2021 | 37321 | 0.080 |
Why?
|
| Viremia | 1 | 2009 | 13 | 0.080 |
Why?
|
| Genome, Viral | 1 | 2009 | 14 | 0.080 |
Why?
|
| Sequence Analysis, RNA | 1 | 2009 | 34 | 0.080 |
Why?
|
| Base Sequence | 1 | 2010 | 1015 | 0.080 |
Why?
|
| Protozoan Proteins | 2 | 2005 | 25 | 0.070 |
Why?
|
| Aged | 3 | 2020 | 14862 | 0.070 |
Why?
|
| Interleukin-4 | 1 | 2006 | 69 | 0.070 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2005 | 22 | 0.070 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2005 | 16 | 0.060 |
Why?
|
| Protozoan Vaccines | 1 | 2005 | 2 | 0.060 |
Why?
|
| Vaccines, DNA | 1 | 2005 | 9 | 0.060 |
Why?
|
| Virus Replication | 1 | 2005 | 104 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2020 | 1174 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 208 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2004 | 69 | 0.060 |
Why?
|
| Antibody Formation | 1 | 2004 | 93 | 0.060 |
Why?
|
| Mutation | 1 | 2009 | 1213 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 2 | 2020 | 199 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2005 | 483 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 532 | 0.050 |
Why?
|
| Infant | 2 | 2006 | 2891 | 0.050 |
Why?
|
| HIV Infections | 1 | 2010 | 791 | 0.050 |
Why?
|
| Age Factors | 1 | 2006 | 1864 | 0.050 |
Why?
|
| Complement C4 | 1 | 2021 | 15 | 0.050 |
Why?
|
| Complement C2 | 1 | 2021 | 9 | 0.050 |
Why?
|
| Metabolomics | 1 | 2021 | 28 | 0.050 |
Why?
|
| Complement C3 | 1 | 2021 | 101 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2006 | 2455 | 0.050 |
Why?
|
| Complement Inactivating Agents | 1 | 2021 | 56 | 0.050 |
Why?
|
| Fatty Acids, Volatile | 1 | 2020 | 8 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2020 | 27 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2020 | 44 | 0.040 |
Why?
|
| Vitamins | 1 | 2021 | 134 | 0.040 |
Why?
|
| Genomics | 1 | 2021 | 168 | 0.040 |
Why?
|
| RNA, Bacterial | 1 | 2020 | 30 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2021 | 376 | 0.040 |
Why?
|
| Transcriptome | 1 | 2021 | 164 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2020 | 144 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 150 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2019 | 59 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2020 | 228 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2020 | 230 | 0.040 |
Why?
|
| Natural Killer T-Cells | 1 | 2018 | 7 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 498 | 0.040 |
Why?
|
| Proteomics | 1 | 2021 | 246 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2018 | 50 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 37 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2020 | 525 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2018 | 156 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 226 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2018 | 201 | 0.040 |
Why?
|
| Protein Binding | 1 | 2020 | 1027 | 0.040 |
Why?
|
| Liver | 1 | 2021 | 1118 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 2093 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2007 | 0.030 |
Why?
|
| Codon | 1 | 2011 | 21 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 1641 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2011 | 114 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 5731 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2011 | 235 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 337 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 261 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 2689 | 0.020 |
Why?
|
| Adolescent | 2 | 2011 | 8912 | 0.020 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2005 | 6 | 0.020 |
Why?
|
| Antibodies, Protozoan | 1 | 2005 | 15 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 189 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2005 | 397 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2005 | 481 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2005 | 597 | 0.010 |
Why?
|
| Pregnancy | 1 | 2005 | 2334 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2005 | 3187 | 0.010 |
Why?
|
| Child | 1 | 2005 | 6405 | 0.010 |
Why?
|